Using a harmless virus to insert a corrective gene into mouse blood cells, scientists at St. Jude Children's Research Hospital have alleviated sickle cell disease pathology. In their studies, the researchers found that the treated mice showed essentially no difference from normal mice. Although the scientists caution that applying the gene therapy to humans presents significant technical obstacles, they believe that the new therapy will become an important treatment for the disease.
- Gene therapy corrects sickle cell disease in laboratory studyWed, 3 Dec 2008, 11:24:00 EST
- Could an old antidepressant treat sickle cell disease?Thu, 21 Feb 2013, 10:09:22 EST
- Researchers find new genetic target for sickle cell disease therapyThu, 4 Dec 2008, 14:37:25 EST
- Correcting sickle cell disease with stem cellsWed, 28 Sep 2011, 22:35:43 EDT
- Gene therapy prevents memory problems in mice with Alzheimer's diseaseSun, 28 Nov 2010, 14:01:18 EST